My #1 Biotech Play for 2024

Don't let Wall Street fool you. ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ ­ Unsubscribe A Message from Weiss Ratings Dear Reader, Don’t let Wall Street fool you. AI is not the only hot sector in the market. Biotech is on fire as well. In fact, the list of 2024’s best stocks is peppered with biotech names. Arcutis Biotherapeutics is up 212% this year alone. Or Janux Therapeutics, up 278% already in 2024. Viking Therapeutics is up 210% so far this year. Now, I believe a new biotech winner could emerge in the coming days. Thanks to a special program created by the FDA. This could be the #1 biotech stock of 2024 and beyond. Click here for more information. Sincerely, Michael Robinson, Editor Disruptors & Dominators P.S. I called AI giant Nvidia at a split-adjusted 80 cents … It’s up 17,062% since I spotted them. And I was ahead of the game on biotech too. I recommended biotech cloud pioneer Veeva Sytems, leading to a 372% gain in a little over three years. I picked Novavax for a 316% gain in 15 months. And in June 2020, while Covid raged around us, I made 375% in just under two months on oral vaccine pioneer Vaxart. Now I believe I’ve found the next handful of biotech winners. And I’ll tell you all about them in this video. Thank you for subscribing to DividendStocks.com's daily newsletter for dividend and income investors that covers ex-dividend stocks, new dividend declarations, dividend stock ideas, and the latest market news.   This message is a paid advertisement sent on behalf of Weiss Ratings, a third-party advertiser of DividendStocks.com and MarketBeat.     11780 US Highway 1, Palm Beach Gardens, FL 33408-3080 Would you like to edit your e-mail notification preferences or unsubscribe from our mailing list?     If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.   If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.   © 2006-2024 MarketBeat Media, LLC. 345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.   Today's Bonus Content: China Buying Up US Farmland In New 'Wuhan-Style' Attack On America?